Promising new study could be life-changing for Type 1 diabetics

Dr. David Thompson, Endocrinologist at Vancouver General Hospital, is the Site Principal Investigator for the ViaCyte Trial. It's a breakthrough study that shows stem cell-based implants are successful in patients with Type 1 Diabetes.